Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Epirubicin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Triple Negative Breast Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 2 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Inflammatory Breast Neoplasms 1 HR+/HER2- Breast Cancer 1 Epstein-Barr Virus Infections 1 Congenital Abnormalities 1 Carcinoma, Adenoid Cystic 1 CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

Specimen Handling 7 Tamoxifen 5 Practice Guidelines as Topic 5 Standard of Care 4 Radiotherapy 3 Methods 3 Sentinel Lymph Node Biopsy 2 Radiation 2 Interviews as Topic 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 pembrolizumab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Telemedicine 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Starch 1 Reverse Transcriptase Polymerase Chain Reaction 1 Ranitidine 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡